Skip to Content Skip to Navigation
1st November 2023 Cancer

New proton therapy research Fellow

Bragg Comprehensive Cancer Centre

Together with the Australian Bragg Centre for Proton Therapy and Research, we are excited to announce Dr Ashwathy Mathew as the new The Hospital Research Foundation Group Bragg Fellow!

Dr Mathew has worked as a Consultant Radiation Oncologist at the Apollo Proton Cancer Centre in Chennai, India – the first proton therapy centre in India.

The Australian Bragg Centre for Proton Therapy and Research is being built on North Terrace, Adelaide, and will be the southern hemisphere’s first proton therapy centre, providing a more targeted therapy for hard-to-access cancers.

“I envisage being a clinician / researcher as part of a world-class team at the centre of excellence in cancer care, positively impacting patients’ lives and the oncology community,” she said.

Dr Mathew is an international medical graduate and alumnus of the Tata Memorial Centre, Mumbai, India (one of the busiest oncology hospitals in India) where she trained as a Junior Resident and subsequently a Senior Resident from 2010 till 2017.

She also holds sub-specialty training through a Fellowship in Lung & Gastrointestinal Oncology (SBRT) at the Princess Margaret Cancer Centre, University of Toronto, Canada.

In her prior work at the Apollo Proton Cancer Centre, Dr Mathew gained considerable experience in establishing and implementing departmental protocols for the treatment of cancers with pencil-beam scanning proton therapy, as well as engaging with both the oncology physician community and the general public regarding appropriate use of proton beam therapy.

Dr Mathew is passionate about advocating for the role of radiation therapy in gastrointestinal cancers, especially liver tumours and has numerous publications to her credit in peer-reviewed national and international journals.

Her other areas of interest include lung cancer radiotherapy, gynaecological cancer radiotherapy, especially brachytherapy and head and neck cancer radiotherapy.

Donate